First part of the presentation provides brief introduction of company MEDICEM, followed by overview of DILAPAN-S and IOL (induction of labour) market. Second part offers you an example of 2022 European communication strategy, incl. unmet needs and DILAPAN-S key benefits.
This website may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for the advice provided by a doctor or other qualified healthcare professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult with a doctor or other healthcare professional. Featured products are not approved in every market, and approved labelling, indications and instructions may vary by country.
This website may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for the advice provided by a doctor or other qualified healthcare professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult with a doctor or other healthcare professional. Featured products are not approved in every market, and approved labelling, indications and instructions may vary by country. Reference the Instructions for Use for a complete listing of indications, warnings and precautions.
© 2013−2024 Dilapan-S®
